GlycoNex Partners with Change Cure to Boost Antibody Program Development GlycoNex has signed a CDMO service agreement with Change Cure to advance their HMGB1-targeted antibody program, marking a significant milestone in drug development.

GlycoNex Partners with Change Cure to Boost Antibody Program Development #Taiwan #New_Taipei_City #GlycoNex #Change_Cure #HMGB1